Akili, Inc (AKLI) Announces FDA Authorization of EndeavorOTC Jun 18, 2024 04:01PM
Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game Jun 18, 2024 04:01PM
Akili Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 04:01PM
Akili, Inc (AKLI) Announces Amended Agreement with Shionogi, Shifts Corporate Strategy Apr 30, 2024 08:03AM
Akili Announces Amended Agreement with Shionogi, Shift in Corporate Strategy and Release Date for First Quarter 2024 Financial Results Apr 30, 2024 08:00AM


Feb 29, 2024 04:01PM Akili Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Nov 9, 2023 04:02PM Akili Reports Third Quarter 2023 Financial Results and Provides Business Update
Aug 10, 2023 04:01PM Akili Reports Second Quarter 2023 Financial Results and Provides Business Update
May 11, 2023 04:01PM Akili Reports First Quarter 2023 Financial Results and Provides Business Update
Mar 7, 2023 04:01PM Akili Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update